Newer GLP-1s, pushback on research cuts, and a protest | STAT

Welcome to the web edition of STAT’s ADA in 30 Seconds newsletter, bringing you the latest updates from the American Diabetes Association’s annual conference. I’m Elizabeth Cooney, reporting live from New Orleans, where the atmosphere is vibrant and the discussions are heated. Join me for the first of three ADA in 30 newsletters, where my colleague Elaine Chen and I will be sharing highlights and insights from this exciting event near the banks of the Mississippi River.

Let’s kick things off with reflections from Rick Woychik, a senior adviser to NIH chief Jay Bhattacharya, who delivered a keynote address in his absence. Our STAT colleague Anil Oza also provides some background information to give you a comprehensive view of the conference proceedings. Stay tuned for more updates and analysis as the weekend unfolds.

If you’re attending the conference as well, don’t hesitate to come and say hello. You can also reach out to me at [email protected] for any questions or feedback.

For exclusive content and in-depth analysis, consider subscribing to STAT+. Unlock this article and gain access to premium events, newsletters, and news alerts to stay informed on the latest developments in the field of diabetes research and treatment.

Thank you for joining us on this journey through the ADA conference, where groundbreaking discoveries and lively debates are shaping the future of diabetes care. Stay tuned for more updates and insights from the conference floor.